PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

45 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Lay all publications on this page into basket
1.
Bartos, L.M.* et al.: Remote neuroinflammation in newly diagnosed glioblastoma correlates with unfavorable clinical outcome. Clin. Cancer Res. 30, 4618-4634 (2024)
2.
Huang, Y.J.* et al.: Targeting c-MET for endoscopic detection of dysplastic lesions within Barrett's esophagus using EMI-137 fluorescence imaging. Clin. Cancer Res., DOI: 10.1158/1078-0432.CCR-24-1522 (2024)
3.
Tawk, B.* et al.: DNA-methylome–based tumor hypoxia classifier identifies HPV-negative head and neck cancer patients at risk for locoregional recurrence after primary radiochemotherapy. Clin. Cancer Res. 29, 3051-3064 (2023)
4.
Wang, J. et al.: Spatial metabolomics identifies distinct tumor-specific subtypes in gastric cancer patients. Clin. Cancer Res. 28, 2865-2877 (2022)
5.
Weber, P. et al.: Therapy-related transcriptional subtypes in matched primary and recurrent head and neck cancer. Clin. Cancer Res. 28, 1038-1052 (2022)
6.
Anande, G.* et al.: RNA splicing alterations induce a cellular stress response associated with poor prognosis inAcute Myeloid Leukemia. Clin. Cancer Res. 26, 3597-3607 (2020)
7.
Hulstaert, E.* et al.: Charting extracellular transcriptomes in The Human Biofluid RNA Atlas. Clin. Cancer Res. 26, 33-34 (2020)
8.
Multhoff, G.* et al.: Targeted natural killer cell-based adoptive immunotherapy for the treatment of patients with NSCLC after radiochemotherapy: A randomized phase II clinical trial. Clin. Cancer Res. 26, 5368-5379 (2020)
9.
Hess J. et al.: A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV-infection. Clin. Cancer Res. 25, 1505-1516 (2019)
10.
Karches, C.H.* et al.: Bispecific antibodies enable synthetic agonistic receptor-transduced T cells for tumor immunotherapy. Clin. Cancer Res. 25, 5890-5900 (2019)
11.
Hensel, T.* et al.: Combined targeting of the Ewing sarcoma transcriptional program by blocking epigenetic readers and transcription initiation via EWS-FLI1. Clin. Cancer Res. 24, 56-56 (2018)
12.
Schmidt, S.* et al.: Development and validation of a gene signature for patients with head and neck squamous cell carcinomas treated by postoperative radio(chemo)therapy. Clin. Cancer Res. 24, 1364-1374 (2018)
13.
von Heyking, K.* et al.: The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype promoting lung metastasis in Ewing sarcoma. Clin. Cancer Res. 24, 57-57 (2018)
14.
Diot, G.* et al.: Multi-spectral optoacoustic tomography (MSOT) of human breast cancer. Clin. Cancer Res. 23, 6912-6922 (2017)
15.
Lamberts, L.E.* et al.: Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: A phase I feasibility study. Clin. Cancer Res. 23, 2730-2741 (2016)
16.
Friemel, J.* et al.: Intratumor heterogeneity in hepatocellular carcinoma. Clin. Cancer Res. 21, 1951-1961 (2015)
17.
Groß, C.* et al.: Model matters: Differences in orthotopic rat hepatocellular carcinoma physiology determine therapy response to sorafenib. Clin. Cancer Res. 21, 4440-4450 (2015)
18.
Lee, M.S. et al.: Targeting PI3K/mTOR signaling displays potent antitumor efficacy against nonfunctioning pituitary adenomas. Clin. Cancer Res. 21, 3204-3215 (2015)
19.
Weber, A.* ; O'Connor, T.* & Heikenwälder, M.: Next generation of preclinical liver cancer models. Clin. Cancer Res. 21, 4254-4256 (2015)
20.
Wulfkuhle, J.D.* et al.: Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin. Cancer Res. 18, 6426-6435 (2012)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮